Table 2.

Literature review of published nomograms applicable to active surveillance patients

First Author	Year	Outcome predicted	PSA	PSAD	Clinical stage	bGS	Variables in nomogram			Age	Biopsy method	MRI	other
							Prostate volume	Tumor volume measure	Benign tissue measure
Partin et al14	1997	Organ confinement, Extracapsular extension, Seminal vesical invasion, Lymph node positivity	x		x	x
Kattan et al15	2003	Low volume, low grade organ confined disease	x		x	x	x	x	x
Nakanishi et al16	2007	Low volume, low grade organ confined disease		x				x		x
Roemeling et al17	2007	Low volume, low grade organ confined disease	x			x	x	x	x
Kulkarni et al18	2007	Upgrading from bx Gleason 6 to Gleason 7 or greater at RP	x		x		x	x		x	x		x
Kattan et al19	2008	Cancer-specific survival for men with clinically localized PCa managed without curative intent	x		x	x		x		x	x		x
Shukla-Dave et al20	2011	Low volume, low grade organ confined disease	x		x		x					x	x
Abdollah et al21	2011	10-yr cancer-specific mortality & other-cause mortality rates with PCa treated with RP or AS			x	x				x			x
O’Brien et al22	2011	Low volume, low grade organ confined disease		x		x	x	x		x
Wong et al23	2012	High grade or high stage Pca		x	x			x		x
Sooriakumar an et al24	2012	Worsening prognosis (either upgrading or upstaging)	x				x	x
Iremashvili et al25	2013	Progression on repeat biopsy		x		x		x					x
Stamatakis et al6	2013	Progression on repeat biopsy						x				x	x
Truong et al26	2013	Gleason score upgrading from Gleason 6		x				x					x

bGS=biopsy Gleason score

PSAD=PSA Density

PCa=Prostate cancer

RP=Radical prostatectomy

AS=Active surveillance